Although soluble CD155 (sCD155) contributes to the neutralization of poliovirus infectivity in vitro (Baury et al., 2003), it remains undetermined how it is involved in tumor immune responses mediated by DNAM-1, TIGIT, and CD96. The gene discussed is PVR; the disease is neoplasm.